Esperion Therapeutics, Inc. Business Finance Contracts & Agreements
32 Contracts & Agreements
- Exchange Agreements (1 contract)
- Indenture Agreements (1)
- Investor Rights Agreements (2)
- Loan Agreements (4)
- Note Agreements (1)
- Purchase Agreements (6)
- Registration Rights Agreements (1)
- Stock Agreements (7)
- Underwriting Agreements (3)
- Warrant Agreements (6)
- Royalty Purchase Agreement by and between the Registrant and OCM IP Healthcare Portfolio LP dated as of June 24, 2024 (Filed With SEC on August 12, 2024)
- The Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan and its Amendments (Filed With SEC on May 28, 2024)
- Underwriting Agreement, dated as of January 18, 2024, by and between Esperion Therapeutics, Inc. and Jefferies LLC, as representative of the several underwriters listed on... (Filed With SEC on January 22, 2024)
- Form of Warrant Amendment Agreement (Filed With SEC on March 22, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 22, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on March 22, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on March 22, 2023)
- Waiver and Amendment No. 3 to Revenue Interest Purchase Agreement and Amendment No. 2 to Security Agreement, by and among the Registrant, the purchasers party thereto, and Eiger... (Filed With SEC on February 21, 2023)
- Form of Warrant to Purchase Common Stock (Filed With SEC on December 7, 2021)
- Underwriting Agreement, dated December 2, 2021, between Esperion Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 7, 2021)
- Exchange Agreement, dated October 22, 2021, by and between Esperion Therapeutics, Inc. and the Holders (Filed With SEC on October 25, 2021)
- Amendment No. 2 to Revenue Interest Purchase Agreement dated April 26, 2021 between the Company, Eiger Partners II LP and Eiger III SA LLC (Filed With SEC on April 26, 2021)
- Amendment No. 1 to the Revenue Interest Purchase Agreement, dated November 11, 2020, by and among the Company, the purchasers from time to time party thereto and Eiger III SA LLC,... (Filed With SEC on February 23, 2021)
- Forward Stock Purchase Confirmation, dated November 11, 2020, between Esperion Therapeutics, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on November 16, 2020)
- Indenture, dated as of November 16, 2020, between Esperion Therapeutics, Inc. and U.S. Bank National Association (Filed With SEC on November 16, 2020)
- Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan, as amended (Filed With SEC on August 10, 2020)
- Esperion Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on May 29, 2020)
- Revenue Interest Purchase Agreement by and between the Company, Eiger III SA LLC, and the Purchasers named therein, dated June 26, 2019 (Filed With SEC on June 26, 2019)
- UNDERWRITING AGREEMENT Esperion Therapeutics, Inc. 3,100,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on August 10, 2017)
- UNDERWRITING AGREEMENT Esperion Therapeutics, Inc. 1,750,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on March 19, 2015)
- UNDERWRITING AGREEMENT Esperion Therapeutics, Inc. 4,250,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on October 16, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on July 2, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on July 2, 2014)
- [] Shares Esperion Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 12, 2013)
- HDL THERAPEUTICS, INC. REGISTRATION RIGHTS AND SECURITYHOLDER AGREEMENT (Filed With SEC on May 14, 2013)
- AMENDMENT NO. 1 TO INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 14, 2013)
- HDL THERAPEUTICS, INC. INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 14, 2013)
- WARRANT TO PURCHASE PREFERRED STOCK (Filed With SEC on May 14, 2013)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 14, 2013)
- Loan and Security Agreement (Filed With SEC on November 10, 2003)
- Loan Modification Agreement (Filed With SEC on March 14, 2002)
- Loan & Security Agreement (Filed With SEC on March 14, 2002)
